In a hurry on a sizzling July morning, Veronica Vallejos opted for the drive-through ATM at Visterra Credit Union in Moreno Valley. After pulling under a carport, she leaned out her window and ...

Investors have given Visterra Inc. a $23.6 million boost as it gets set for new clinical trials of a drug to treat flu patients. Visterra engineers biological drugs to treat illnesses. In ...

Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc. today announced that it will present new preclinical data on VIS410, a novel monoclonal antibody in development for treatment of hospitalized ...

GroundsPRO joins Oberson's under the Visterra umbrella as part of the national commercial landscaping platform's expansion in the Ohio, Kentucky, and Indiana region CHICAGO, IL / ACCESSWIRE ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc., a clinical-stage biotechnology company that uses its proprietary technology platform to identify unique disease targets and design novel ...

Visterra has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, but the offering is ...

Visterra has extended its series C round to fund the advance of its lead candidate into phase 2b. The extension puts Visterra back on the multifront path through the clinic it plotted out before ...

Visterra has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing. The company intends ...

Visterra, Inc., developer of novel therapeutics to prevent and treat major infectious diseases, today announced that FierceBiotech has named it as one of 2013's "Fierce 15," designating Visterra ...